» Articles » PMID: 34442108

Multimodal Early Alzheimer's Detection, a Genetic Algorithm Approach with Support Vector Machines

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease that mainly affects older adults. Currently, AD is associated with certain hypometabolic biomarkers, beta-amyloid peptides, hyperphosphorylated tau protein, and changes in brain morphology. Accurate diagnosis of AD, as well as mild cognitive impairment (MCI) (prodromal stage of AD), is essential for early care of the disease. As a result, machine learning techniques have been used in recent years for the diagnosis of AD. In this research, we propose a novel methodology to generate a multivariate model that combines different types of features for the detection of AD. In order to obtain a robust biomarker, ADNI baseline data, clinical and neuropsychological assessments (1024 features) of 106 patients were used. The data were normalized, and a genetic algorithm was implemented for the selection of the most significant features. Subsequently, for the development and validation of the multivariate classification model, a support vector machine model was created, and a five-fold cross-validation with an AUC of 87.63% was used to measure model performance. Lastly, an independent blind test of our final model, using 20 patients not considered during the model construction, yielded an AUC of 100%.

Citing Articles

Synthetic data analysis for early detection of Alzheimer progression through machine learning algorithms.

Sanchez Reyna A, Mendoza-Gonzalez R, Luna-Garcia H, Celaya Padilla J, Morgan Benita J, Espino-Salinas C PeerJ Comput Sci. 2025; 10:e2437.

PMID: 39896407 PMC: 11784714. DOI: 10.7717/peerj-cs.2437.


Machine learning based algorithms for virtual early detection and screening of neurodegenerative and neurocognitive disorders: a systematic-review.

Yousefi M, Akhbari M, Mohamadi Z, Karami S, Dasoomi H, Atabi A Front Neurol. 2024; 15:1413071.

PMID: 39717687 PMC: 11663744. DOI: 10.3389/fneur.2024.1413071.


Multimodal learning of clinically accessible tests to aid diagnosis of neurodegenerative disorders: a scoping review.

Huang G, Li R, Bai Q, Alty J Health Inf Sci Syst. 2023; 11(1):32.

PMID: 37489153 PMC: 10363100. DOI: 10.1007/s13755-023-00231-0.


Metabolomic Selection in the Progression of Type 2 Diabetes Mellitus: A Genetic Algorithm Approach.

Morgan-Benita J, Sanchez-Reyna A, Espino-Salinas C, Oropeza-Valdez J, Luna-Garcia H, Galvan-Tejada C Diagnostics (Basel). 2022; 12(11).

PMID: 36428864 PMC: 9689091. DOI: 10.3390/diagnostics12112803.


Hard Voting Ensemble Approach for the Detection of Type 2 Diabetes in Mexican Population with Non-Glucose Related Features.

Morgan-Benita J, Galvan-Tejada C, Cruz M, Galvan-Tejada J, Gamboa-Rosales H, Arceo-Olague J Healthcare (Basel). 2022; 10(8).

PMID: 35893185 PMC: 9331873. DOI: 10.3390/healthcare10081362.

References
1.
Pfeffer R, Kurosaki T, Harrah Jr C, Chance J, Filos S . Measurement of functional activities in older adults in the community. J Gerontol. 1982; 37(3):323-9. DOI: 10.1093/geronj/37.3.323. View

2.
Celaya-Padilla J, Galvan-Tejada C, Lopez-Monteagudo F, Alonso-Gonzalez O, Moreno-Baez A, Martinez-Torteya A . Speed Bump Detection Using Accelerometric Features: A Genetic Algorithm Approach. Sensors (Basel). 2018; 18(2). PMC: 5856042. DOI: 10.3390/s18020443. View

3.
Frozza R, Lourenco M, De Felice F . Challenges for Alzheimer's Disease Therapy: Insights from Novel Mechanisms Beyond Memory Defects. Front Neurosci. 2018; 12:37. PMC: 5808215. DOI: 10.3389/fnins.2018.00037. View

4.
Zhang D, Wang Y, Zhou L, Yuan H, Shen D . Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage. 2011; 55(3):856-67. PMC: 3057360. DOI: 10.1016/j.neuroimage.2011.01.008. View

5.
Stamate D, Kim M, Proitsi P, Westwood S, Baird A, Nevado-Holgado A . A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort. Alzheimers Dement (N Y). 2020; 5:933-938. PMC: 6928349. DOI: 10.1016/j.trci.2019.11.001. View